Skip to main content
. Author manuscript; available in PMC: 2018 Nov 15.
Published in final edited form as: Eur J Pharm Sci. 2017 Jul 31;109:182–190. doi: 10.1016/j.ejps.2017.07.034

Fig. 4.

Fig. 4

Determination of KI and kinact for inactivation of CYP3A4 (midazolam) by licochalcone A. (A) Time- and concentration-dependent inactivation of CYP3A4 (midazolam) by licochalcone A. (B) Non-linear regression analysis of kobs,app. Activity is expressed as a percentage of remaining activity compared with the control containing no inhibitor. Experiments were carried out three times.